APA (7th ed.) Citation

QQ, S., XC, Y., M, Y., J, M., JB, Z., L, Y., . . . SZ, D. (2022). Rabeprazole plus amoxicillin dual therapy is equally effective to bismuth-containing quadruple therapy for Helicobacter pylori eradication in central China: A single-center, prospective, open-label, randomized-controlled trial. Helicobacter, 27(2), e12876. https://doi.org/10.1111/hel.12876

Chicago Style (17th ed.) Citation

QQ, Shao, et al. "Rabeprazole Plus Amoxicillin Dual Therapy Is Equally Effective to Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication in Central China: A Single-center, Prospective, Open-label, Randomized-controlled Trial." Helicobacter 27, no. 2 (2022): e12876. https://doi.org/10.1111/hel.12876.

MLA (9th ed.) Citation

QQ, Shao, et al. "Rabeprazole Plus Amoxicillin Dual Therapy Is Equally Effective to Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication in Central China: A Single-center, Prospective, Open-label, Randomized-controlled Trial." Helicobacter, vol. 27, no. 2, 2022, p. e12876, https://doi.org/10.1111/hel.12876.